He Lou
Biographic Data
| ID | 7309786 |
|---|---|
| NAME | He Lou |
| GIVEN NAMES | He |
| FAMILY NAME | Lou |
| SIGNATURE | LOU H |
| AFFILIATIONS | Zhejiang University |
| ORCID | 0000-0002-9235-5700 |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Reduning injection and its effective constituent luteoloside protect against sepsis partly via inhibition of HMGB1/TLR4/NF-κB/Mapks signaling pathways
RDN and its effective constituent luteoloside exhibited a significant protective effect against sepsis, which were potential candidate drugs for treatment of sepsis. The mechanism of antisepsis partly was related to inhibition of HMGB1/TLR4/NF-κB/MAPKs signaling pathways. The results provide an evidence base for the follow-up clinical application of RDN in treatment of sepsis
No prominent works on this page.
Reduning injection and its effective constituent luteoloside protect against sepsis partly via inhibition of HMGB1/TLR4/NF-κB/Mapks signaling pathways
RDN and its effective constituent luteoloside exhibited a significant protective effect against sepsis, which were potential candidate drugs for treatment of sepsis. The mechanism of antisepsis partly was related to inhibition of HMGB1/TLR4/NF-κB/MAPKs signaling pathways. The results provide an evidence base for the follow-up clinical application of RDN in treatment of sepsis
Advanced Glycation End Products research (1 works) · Biology (1 works) · Ex vivo (1 works) · Gardenia jasminoides (1 works) · Immune Response and Inflammation (1 works) · Immunology (1 works) · In vivo (1 works) · Inflammation (1 works) · Lipopolysaccharide (1 works) · Medicine (1 works)